BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 112978
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112978
Table 1 Baseline characteristics of type B aortic dissection patients stratified by aortic remodeling status, n (%)/mean ± SD

Favorable remodeling group (n = 95)
Adverse remodeling group (n = 45)
t/χ²
P value
Sex
Male49 (51.58) 22 (48.89) 0.0880.766
Female46 (48.42) 23 (51.11)
Age57.37 ± 13.9756.84 ± 14.340.2050.837
Comorbidity
Hypertension90 (94.74) 39 (86.67) 2.750.097
Diabetes46 (48.42) 23 (51.11) 0.0880.766
Coronary heart disease34 (35.79) 14 (31.11) 0.2970.586
Hyperlipidaemia37 (38.95) 15 (33.33) 0.4120.521
Chronic renal failure7 (7.37) 4 (8.89) 0.0980.755
Smoking history29 (30.53) 10 (22.22) 1.0480.306
Alcohol consumption19 (20) 12 (26.67) 0.7870.375
Pain location
Chest pain/Back pain47 (49.47) 24 (53.33) 0.1820.670
Abdominal pain
10 (10.53) 6 (13.33) 0.2380.626
Chest and abdominal pain38 (40) 15 (33.33) 0.5770.448
BMI23.64 ± 7.6422.15 ± 9.451.0420.299
Table 2 Comparison of imaging and surgical data between groups, n (%)/mean ± SD

Favorable remodeling group (n = 95)
Adverse remodeling group (n = 45)
t/χ²
P value
True lumen diameter at primary entry tear14.45 ± 4.6911.13 ± 3.684.1370.001
False lumen diameter at primary entry tear (mm)17.05 ± 2.0520.42 ± 3.58-7.0610.001
True lumen diameter at T12 level (mm)12.66 ± 3.6210.24 ± 3.283.8040.001
False lumen diameter at T12 level (mm)15.20 ± 1.8519.58 ± 2.77-11.0600.001
Extent of false lumen involvement
Thoracic aorta7 (7.37) 07.4610.024
Suprarenal abdominal aorta41 (43.16) 13 (28.89)
Thoracoabdominal aorta47 (49.47) 32 (71.11)
Branch vessels from false lumen 1.95 ± 0.662.49 ± 0.84-4.1430.001
Entry tears in descending aorta3.04 ± 0.823.13 ± 0.82-0.6140.540
Entry tears in abdominal aorta1.95 ± 0.661.93 ± 0.650.1180.906
Patency of false lumen34 (35.79)29 (64.44)10.1310.002
Timing of surgery
Acute phase4 (4.21) 9 (20) 17.6720.001
Subacute phase88 (92.63) 29 (64.44)
Chronic phase3 (3.16) 7 (15.56)
Operative duration (minute)70.56 ± 15.1269.73 ± 17.880.0630.95
Intraoperative blood loss (mL)29.47 ± 12.9332.12 ± 15.24-0.2240.823
Left subclavian artery revascularization
Performed33 (34.74) 19 (42.22) 0.7330.392
Not performed62 (65.26) 26 (57.78)
Table 3 Multivariable logistic regression analysis of aortic adverse remodeling predictors
Variable1
β
SE
Wald χ²
OR
95%CI
P value
True lumen diameter at primary entry tear-0.0710.0940.5760.9310.774-1.1200.448
False lumen diameter at primary entry tear (mm)0.4450.13510.8201.5611.197-2.0350.001
True lumen diameter at T12 level (mm)-0.1030.1031.0000.9020.736-1.1040.317
False lumen diameter at T12 level (mm)0.5890.16512.8071.5640.894-1.7660.001
False lumen involvement: Thoracic aorta-0.3140.0757.1250.9250.614-0.8310.015
False lumen involvement: Suprarenal abdominal aorta-0.3690.7510.2420.6910.159-3.0110.023
False lumen involvement: Thoracoabdominal aorta8.54512.25424.68711.7519.841-15.6120.001
Branch vessels from false lumen0.4670.5170.8161.5950.579-4.3900.366
Patency of false lumen1.7300.7215.7515.6394.372-8.1810.004
Acute phase intervention1.4760.2845.1181.1750.886-1.9250.045
Subacute phase intervention-1.4971.1041.8390.2240.026-1.9470.175
Chronic phase intervention-1.2480.8561.1250.2870.014-1.5370.145